ADAM23 and esophageal squamous cell carcinoma: The findings revealed that ARHGEF26-AS1 acts as a miR-372-3p sponge that regulates the neuropeptide LGI1 receptor ADAM23 expression, thereby inhibiting the proliferation and migration of ESCC cells as well as upregulating the ferroptosis pathway.